Van Eyk Awarded AHA Grant for Heart Study
Jennifer Van Eyk, PhD, director of the Cedars-Sinai Advanced Clinical Biosystems Research Institute, has been awarded $2 million by the American Heart Association for a study seeking to identify novel blood proteins that consistently predict cardiovascular risk across diverse patient cohorts.
Van Eyk, who also is director of Basic Science at the Barbra Streisand Woman’s Heart Center at the Cedars-Sinai Heart Institute and the Erika J. Glazer Chair in Women's Heart Health, will share the four-year Grand Challenge Award with Daniel J. Rader, MD, Seymour Gray Professor of Molecular Medicine and chair of the Department of Genetics at the University of Pennsylvania Perelman School of Medicine.
Van Eyk and Rader are co-principal investigators on a project that will generate data on blood protein biomarkers from people of European, African-American and South Asian ancestry and their relationship to genetic variants and the risk of heart disease. "We hope we can use this information to make a test that can be used in a family doctor’s visit or in the hospital," Van Eyk said.
The award is part of the American Heart Association's Cardiovascular Genome-Phenome Study program, which funds research to accelerate the discovery of personalized treatments and prevention of cardiovascular diseases. The program enables researchers to simultaneously access massive volumes of data from multiple studies, including the famed Framingham Heart Study and Jackson Heart Study.